Investigating synthetic mimics of glycosaminoglycans to regulate blood cell production.
Synthetic glycosaminoglycan mimetics as regulators of megakaryopoiesis and thrombopoiesis
This study is looking at how special synthetic compounds can help boost the production of platelets, which are important for stopping bleeding, and it's aimed at finding new ways to improve blood clotting for people who might need it.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas NIH-funded |
| Lab location | 1 site (Denton, United States) |
| Project ID | NIH-11126986 on NIH RePORTER |
What this research studies
This research focuses on understanding how synthetic glycosaminoglycan mimetics can influence the production of platelets from megakaryocytes, which are essential for blood clotting. The principal investigator, a postdoctoral scholar, will utilize advanced techniques to study the interactions between these mimetics and proteins involved in blood cell formation. By developing non-saccharide glycosaminoglycan mimetics, the research aims to uncover new regulatory mechanisms that could enhance or control platelet production in the body.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions affecting platelet production or function, such as thrombocytopenia or thrombocytosis.
Not a fit: Patients with stable platelet counts and no history of blood disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies for conditions related to abnormal platelet levels, improving patient outcomes in bleeding disorders or thrombosis.
How similar studies have performed: Previous research has shown promise in using glycosaminoglycan mimetics for various biological applications, suggesting potential for success in this novel approach.
Where this research is happening
Denton, United States
- University of North Texas — Denton, United States (Active)
Researchers
- Principal investigator: Afosah, Daniel Kwame — University of North Texas
- Study coordinator: Afosah, Daniel Kwame
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.